Wolters Kluwer Health - Lippincott Williams & Wilkins

Registered Users

User Name:
Password:
Register   Forgotten Password
Enter your email address:
  • Conferences
  • Free Content
  • Hot Topics
  • News
  • Archive
  • Contact Us
  • Home
  • Publish With Us
  • Partnerships in Focus
  • Current Focus
  • Conference Focus
  • Society Partners
  • News
  • Contact Us
  • Resources
  • Download Centre
  • About Us
  • Sustainability
  • Register

Cancer Prevention banner

You are here: Home » Oncology » Somatic mutations in cancer

Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes

Cover of Current Opinion in OncologyOlivier & Taniere
Current Opinion in Oncology 23 (1) January 2011
ISSN: 1040-8746 • Frequency: 6/year • Subscribe Now

This study reviews recent data on the prognostic and predictive value of intragenic somatic mutations in TP53 and EGFR genes.


Read this Article

 

 


 

 

Don't miss out - further Free LWW Content is available for registered users! Log into your account or register here to read these articles

 

 

 

Bookmark and Share

Oncology button
Radiology button
Pathology Archive
Mental Health button
HIV AIDS Focus
Emergency Medicine button
Gastroenterology button
Neurology button
Cardiology button
Infectious Diseases Archive
Aneasthesiology Archive
Conferences


©2012 Lippincott Williams & Wilkins
Judd Associates: Sussex Web Design
  • Site Map
  • Accessibility
  • Privacy
Follow us on Facebook and Twitter